What is Quartesian?
Quartesian operates as a specialized Clinical Data Company, providing critical analytical insights to organizations engaged in complex clinical studies. The firm distinguishes itself through a unique synthesis of deep technical expertise and extensive industry experience, enabling the delivery of high-quality data services that are both efficient and cost-effective. Serving a diverse portfolio of over 250 global customers, Quartesian supports clinical trials across all phases and scales, ensuring that research sponsors receive the data integrity and innovation required to navigate the rigorous regulatory environments of modern medicine. Its market position is defined by a commitment to consistent excellence and a scalable service model that adapts to the evolving needs of the pharmaceutical and biotechnology sectors.
How much funding has Quartesian raised?
Quartesian has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Quartesian
PPP
Public-Private Partnership
What's next for Quartesian?
With the successful completion of this late-stage financing, Quartesian is poised to enter a new phase of operational maturity. The strategic allocation of this capital will likely focus on enhancing the company's proprietary data platforms and expanding its specialized service teams to meet the increasing demand for outsourced clinical data management. As the industry shifts toward more decentralized and data-intensive trial models, Quartesian's focus on technological innovation and process optimization will be paramount. Investors and stakeholders can expect the company to prioritize long-term value creation through the integration of advanced analytics and the continued pursuit of operational efficiencies that define its competitive advantage in the global clinical research market.
See full Quartesian company page
